miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway

MicroRNAs (miRNAs) inhibit or improve the malignant progression of hepatocellular carcinoma (HCC). We previously reported that compared to health controls, patients with liver cirrhosis present the highest levels of circulating miR-885-5p, followed by those with chronic hepatitis B and those with HCC. However, the molecular involvement of miR-885-5p in HCC metastasis is presently unclear. Here, we demonstrated that the expression of miR-885-5p negatively correlated with the invasive and metastatic capabilities of human HCC tissue samples and cell lines. We found that miR-885-5p expression levels correlated with the survival of patients with HCC. Overexpression of miR-885-5p decreased metastasis of HCC cells in vitro and in vivo. Inhibition of miR-885-5p improved proliferation of non-metastatic HCC cells. Furthermore, we disclosed that miR-885-5p targeted gene encoding β-catenin CTNNB1, leading to decreased activity of the Wnt/β-catenin signaling pathway. The present study indicates that miR-885-5p suppresses the metastasis of HCC and inhibits Wnt/β-catenin signaling pathway by its CTNNB1 target, which suggests that miR-885-5p to be a promising negative regulator of HCC progression and as a novel therapeutic agent to treat HCC.

[1]  David L. Thomas,et al.  Global control of hepatitis C: where challenge meets opportunity , 2013, Nature Medicine.

[2]  M. Heikenwalder,et al.  Direct Effects of Hepatitis B Virus-Encoded Proteins and Chronic Infection in Liver Cancer Development , 2013, Digestive Diseases.

[3]  C. Croce,et al.  MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. , 2009, Cancer research.

[4]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[5]  K. Basler,et al.  β-Catenin hits chromatin: regulation of Wnt target gene activation , 2009, Nature Reviews Molecular Cell Biology.

[6]  H. Ruan,et al.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. , 2010, European journal of cancer.

[7]  K. Horimoto,et al.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.

[8]  Ding‐Shinn Chen,et al.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. , 2009, Gastroenterology.

[9]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[10]  H. Kidoya,et al.  microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin , 2013, Oncogene.

[11]  Ming Yao,et al.  MicroRNA‐30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma , 2010, Hepatology.

[12]  R. Xiang,et al.  SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network. , 2013, Cancer letters.

[13]  T. Jiang,et al.  Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme , 2011, Brain Research.

[14]  J. López-Guerrero,et al.  miRNAs as biomarkers in prostate cancer , 2012, Clinical and Translational Oncology.

[15]  Subrata Sen,et al.  Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer , 2014, Molecules.

[16]  M. Piris,et al.  The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. , 2012, Blood.

[17]  Jianren Gu,et al.  Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma , 2008, International journal of cancer.

[18]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[19]  Peng-jun Zhang,et al.  Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.

[20]  Yaping Tian,et al.  Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma , 2012, Cancer biology & therapy.

[21]  Shuang Wu,et al.  microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma , 2014, Digestive Diseases and Sciences.

[22]  J. Yun,et al.  MicroRNA‐195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells , 2009, Hepatology.

[23]  C. Croce,et al.  miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ , 2012, Oncogene.

[24]  Jian-Jun Wei,et al.  miR-106a Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma , 2013, Molecular Cancer Research.

[25]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[26]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[27]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[28]  Li Lin,et al.  Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.

[29]  Neveen Abd El Moneim Hussein,et al.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer , 2016, Journal of Cancer Research and Clinical Oncology.

[30]  D. Stupack,et al.  SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells. , 2014, Carcinogenesis.

[31]  S. Bojesen,et al.  MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.

[32]  Jing Ping Zhang,et al.  MicroRNA‐29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression , 2011, Hepatology.

[33]  U. Pastorino,et al.  Role of MicroRNAs in Lung Cancer: MicroRNA Signatures in Cancer Prognosis , 2012, Cancer journal.

[34]  P. Igaz,et al.  MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas , 2010, Modern Pathology.

[35]  F. Westermann,et al.  MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival , 2011, Cell Death and Differentiation.

[36]  C. Croce,et al.  MicroRNAs in the pathogeny of chronic lymphocytic leukaemia , 2007, British journal of haematology.